Related Experiment Video
Updated: Jul 7, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Incidentally simultaneous occurrence of RET/PTC, H4-PTEN and BRAF mutation in papillary thyroid carcinoma
Yu-Long Wang1, Jiu-Cun Wang, Yi Wu
1Department of Head & Neck Surgery, Cancer Hospital, Fudan University, 270 Dong'an Road, Shanghai 200032, China.
Abstract:
Because interaction existed between PTEN and RET-RAS-RAF-MAPK pathway, H4-PTEN (a newly identified gene rearrangement), RET/PTC and BRAF mutation were scanned in 125 Chinese patients with papillary thyroid carcinoma (PTC). H4-PTEN were detected in 9.6% of PTC and the frequency of the occurrence of BRAF mutation and/or RET/PTC in H4-PTEN positive tumors was extremely high (75%). On the other hand, age has an important effect on the aberration formation and young age renders more prone to multi-genetic events. A combinational scanning of these involved changes will improve the predictive value of molecular aberrations in the treatment of PTC.
Insights
A new gene rearrangement, H4-PTEN, was found in 9.6% of papillary thyroid carcinoma (PTC) patients. Its presence strongly correlates with BRAF mutations and RET/PTC, suggesting combined molecular analysis for better PTC treatment prediction.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The PTEN and RET-RAS-RAF-MAPK pathways are crucial in cell signaling.
- Gene rearrangements and mutations are implicated in papillary thyroid carcinoma (PTC) development.
- Understanding these molecular alterations is key for targeted therapies.
Purpose of the Study:
- To investigate the frequency of H4-PTEN, RET/PTC, and BRAF mutations in Chinese PTC patients.
- To explore the relationship between H4-PTEN and other common genetic alterations.
- To assess the impact of age on genetic aberration formation in PTC.
Main Methods:
- Genomic DNA was extracted from 125 Chinese patients with papillary thyroid carcinoma.
- Screening for H4-PTEN gene rearrangement.
- Analysis for RET/PTC rearrangements and BRAF mutations.
Main Results:
- H4-PTEN was detected in 9.6% of PTC cases.
- In H4-PTEN positive tumors, 75% exhibited BRAF mutation and/or RET/PTC.
- Younger age was associated with a higher likelihood of multiple genetic events.
Conclusions:
- H4-PTEN is a novel genetic alteration in PTC.
- H4-PTEN positivity is strongly linked to BRAF mutations and RET/PTC.
- Combined molecular profiling, considering age, may enhance PTC treatment prediction.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
